How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Oxygen Concentrator Molecular Sieve Market
- By Product Type: Pressure Swing Adsorption (PSA) Oxygen Concentrators, Membrane Oxygen Concentrators, Portable Oxygen Concentrators, Stationary Oxygen Concentrators
- By Molecular Sieve Material: Zeolite Molecular Sieves, Carbon Molecular Sieves, Silica Gel Molecular Sieves, Alumina Molecular Sieves
- By End-User: Hospitals and Clinics, Home Healthcare, Industrial Applications, Emergency Medical Services (EMS)
- By Oxygen Purity Level: Low Purity (85-90%), Medium Purity (90-95%), High Purity (95-99%)
- By Capacity: Low Capacity (up to 5 LPM), Medium Capacity (5-10 LPM), High Capacity (above 10 LPM)
Top segment
Pressure Swing Adsorption (PSA) Oxygen Concentrators XX% share · $X,XXXM
In the full report →
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Pressure Swing Adsorption (PSA) Oxygen Concentrators leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Oxygen Concentrator Molecular Sieve Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Molecular Sieve Material 4
End-User 4
Oxygen Purity Level 3
Capacity 3
Companies profiled
Philips Respironics
Invacare Corporation
DeVilbiss Healthcare
Drive DeVilbiss Healthcare
Inogen Inc.
AirSep Corporation (a Chart Industries company)
Nidek Medical Products
Fisher & Paykel Healthcare
ResMed Inc.
Longfian Scitech
Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
BMC Medical Co. Ltd.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Respironics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Invacare Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →DeVilbiss Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Drive DeVilbiss Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Inogen Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →AirSep Corporation (a Chart Industries company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nidek Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Fisher & Paykel Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →ResMed Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Longfian Scitech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BMC Medical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Oxygen Concentrator India Pvt Ltd
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Caire Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,578M by 2033 · 11.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Pressure Swing Adsorption (PSA) Oxygen Concentrators61.6
- Membrane Oxygen Concentrators11.1
- Portable Oxygen Concentrators14.8
- Stationary Oxygen Concentrators12.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$896.1M → $2,062M · 11.0%
Europe$624.6M → $1,453M · 11.1%
Asia Pacific$570.3M → $1,328M · 11.2%
Latin America$353.0M → $939.6M · 13.0%
Middle East and Africa$271.6M → $634.6M · 11.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.642026
11.662027
11.672028
11.692029
11.692030
11.702031
11.732032
11.732033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Respironics16.5
- Invacare Corporation23.1
- DeVilbiss Healthcare5.5
- Drive DeVilbiss Healthcare12.3
- Inogen Inc.7.8
- AirSep Corporation (a Chart Industries company)6.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type19.9%
Molecular Sieve Material16.5%
End-User30.9%
Oxygen Purity Level11.4%
Capacity21.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe22.6
- Asia Pacific20.7
- Latin America14.6
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Respironics | 78 | 85 | 94 | 99 | 97 | 75 | 88 |
| Invacare Corporation | 90 | 75 | 90 | 71 | 73 | 91 | 82 |
| DeVilbiss Healthcare | 63 | 62 | 69 | 71 | 74 | 63 | 67 |
| Drive DeVilbiss Healthcare | 75 | 72 | 63 | 65 | 74 | 64 | 69 |
| Inogen Inc. | 59 | 61 | 68 | 59 | 60 | 71 | 63 |
| AirSep Corporation (a Chart Industries company) | 70 | 52 | 64 | 48 | 66 | 47 | 58 |
| Nidek Medical Products | 60 | 41 | 53 | 66 | 48 | 43 | 52 |
| Fisher & Paykel Healthcare | 43 | 36 | 44 | 55 | 40 | 53 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Respironics
- Invacare Corporation
- DeVilbiss Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Respironics | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Invacare Corporation | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| DeVilbiss Healthcare | ◐ | − | − | ✓ | ◐ | ◐ |
| Drive DeVilbiss Healthcare | ✓ | ✓ | − | ◐ | ✓ | − |
| Inogen Inc. | ◐ | − | ◐ | − | − | ◐ |
| AirSep Corporation (a Chart Industries company) | ◐ | ◐ | − | − | ✓ | − |
| Nidek Medical Products | ◐ | − | ◐ | − | − | − |
| Fisher & Paykel Healthcare | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Philips Respironics88
2Invacare Corporation82
3Drive DeVilbiss Healthcare69
4DeVilbiss Healthcare67
5Inogen Inc.63
6AirSep Corporation (a Chart Industries company)58
7Nidek Medical Products52
8Fisher & Paykel Healthcare45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Philips RespironicsInvacare Corporation
Challenger2
Strong scale, closing on the leaders.
DeVilbiss HealthcareDrive DeVilbiss Healthcare
Contender2
Focused players with pockets of strength.
Inogen Inc.AirSep Corporation (a Chart Industries company)
Niche2
Specialists in a single segment or region.
Nidek Medical ProductsFisher & Paykel Healthcare
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Oxygen Concentrator Molecular Sieve Market — a $443M beachhead inside a $7.30B market.
Beachhead (SOM)$443Mobtainable near-term
Serviceable (SAM)$3.05Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Pressure Swing Adsorption (PSA) Oxygen Concentrators
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Membrane Oxygen Concentrators
Strong fit — clear ROI and a fast path to value.
End user67 fit
Portable Oxygen Concentrators
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Molecular Sieve Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Oxygen Concentrator Molecular Sieve Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified24%
Evaluation13%
Closed-won7%
$15.9KCAC
$82KLTV
5.1:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Oxygen Concentrator Molecular Sieve Market is a high-growth opportunity — $10.8B by 2033, compounding at 11.4%.
TAM · 2025$4.55Btoday
TAM · 2033$10.8Bforecast
CAGR11.4%2027–2033
Cumulative$65.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.8BTotal addressable market
SAM$3.84BServiceable available market
SOM$713MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.8BLarge & growingTAM by 2033 at 11.4% CAGR
$3.84BServiceable nowreachable with today’s model
$713MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.40BBear7.4% CAGR
$10.8BBase11.4% CAGR
$13.8BBull15.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Molecular Sieve Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Oxygen Concentrator Molecular Sieve Market — a $5.17B market by 2033. Plan: grow share from 8.0% to 13.0%.
Market size · 2033$5.17Btotal addressable
Market CAGR4.8%2027–2033
Target share13.0%from 8.0% today
Revenue ambition$672Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 13.0% | Ahead |
| Revenue | $452M | $672M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.2% | 45.0% | Behind |
| Customer retention | 87.9% | 95.9% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Molecular Sieve Material capability
A defensible second engine — invest in Molecular Sieve Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Molecular Sieve Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $86M capacity & capability investment
- Greenlight bolt-on M&A in Molecular Sieve Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Oxygen Concentrator Molecular Sieve Market conversation — a $3.80B market you can size, segment and defend in minutes.
Market size · 2033$3.80Btotal opportunity
Growth11.5%CAGR to 2033
Addressable buyers1,309+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 2 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Philips RespironicsInvacare CorporationDeVilbiss HealthcareDrive DeVilbiss HealthcareInogen Inc.AirSep Corporation (a Chart Industries company)Nidek Medical ProductsFisher & Paykel Healthcare+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Oxygen Concentrator Molecular Sieve Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Oxygen Concentrator Molecular Sieve Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Oxygen Bubble Humidifier Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportOxygen Breathing Mask Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportOxygen Breathing Equipment Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportOxygen Bar Equipment Market
Market size, share, segmentation and regional forecast.
$365M market · 2025 base year
View reportOxygen Bag Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportOxygenator Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportOxygenation Pump Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportOxygen and Aerosol Delivery Devices Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportOxycodone Hydrochloride Extended-Release Tablets Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportOxycodone Hydrochloride Extended-Release Drug Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportOxycodone Hydrochloride Drugs Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportOxycodone Hydrochloride API Market
Market size, share, segmentation and regional forecast.
$971M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.